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While acute fibrosis is associated to tissue repair, chronic fibrosis associated with solid 
carcinomas results in perpetual deregulation of the normal wound healing process with 
upregulation/secretion of extracellular matrix (ECM) proteins and cytokines. In the later, 
human Tumour Stromal Myofibroblasts (TSMs) get activated and adopt a myofibroblast-like 
phenotype with a high contractile, proliferative phenotype, and increased ECM/cytokine 
production/secretion profile. This creates a new and dynamic environment characterized by 
remarkable matrix stiffness, which contributes to maintain TSM’ activated phenotype and 
increased tissue tension. It is known that TSMs can migrate towards the tumour area in 
response to chemokine activation and cross talk with cancer cells to promote tumour growth. 
However, whether or not TSM can migrate to the tumour guided by mechanical taxis has not 
been studied yet. Elucidating the ability of TSM to display durotactic behaviour and studying 
this in detail will provide crucial information for the development of therapies for solid 
carcinomas and fibrosis. 
In this project Tumour Stromal Myofibroblasts were plated on PAA gels with double rigidity 
gradient – 4 kPa, low rigidity healthy tissue stiffness and 25 kPa, fibrotic tissue rigidity, to 
assess cell ability to migrate towards less compliant substrate mimicking movement towards 
fibrotic sites. Fluorescent nanobeads labelling the 25 kPa gel side indicated the transition 
region between both rigidities. Acrylamide/bisacrylamide 4 kPa and 25 kPa working solutions 
were prepared from reagents according to the table 1. 25 kPa solution was labelled by 
adding 2.5 µl FluoSpheres carboxylate 0.2 um, yellow-green (Molecular Probes, cat. F8811). 
To create a gradient rigidity for the durotaxis assay two droplets, each containing 4 µl of the 
4 kPa and 25 kPa gel, were placed adjacent to each other on a hydrophobic microscope 
slide. A 13 mm activated coverslip was placed on the droplets avoiding the liquids to mix. 
Regions of different rigidities were distinguished by fluorescent beads embedded in the 
stiffer part of the substrate. After 45 minutes of polymerization gel-coated coverslips were 
gently removed and crosslinked with fibronectin by photoactivated Sulfo-SANPAH. Cells 
were seeded following the one hour gel incubation with the culture medium. Thirty minutes 
after seeding the migration of cells was recorded by video time lapse microscopy with phase 
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contrast for 5 h 45 min. Observation was made in boundary, soft and stiff region with ~70 
cells per region. The rigidity gradient from soft to stiff is marked / imaged by increasing 
density of fluorescent beads which contained the 25 kPa gel (Fig. 1). Cell movement 
distance in each stiffness and boundary region was calculated by subtraction of initial (at 0 
h) and final (at 5 h 45 min) x, in gradient axis, and y, perpendicular to gradient axis, cell 
position coordinates.  
The results demonstrated that the highly effective durotactic response is induced and 
directed by the rigidity gradient. It has been shown that fibroblasts are able to migrate 
towards higher rigidity1, 2, but in this experiment durotaxis was shown for the first time in the 
context of modelling the migration of TSM into fibrotic sites. Our results demonstrated that 
TSM subjected to relatively lower gradients, mimicking diseased tissue, are also able to 
sense the rigidity difference and undergo the durotactic response. This outcome adds 
another important factor that has to be taken into account in designing anti-fibrotic treatment. 
The gradient model as proposed in our research, resembles changes of a soft to stiff 
microenvironment, which can be caused by TSM ECM production residing at wound/fibrotic 
sites. We demonstrated that increased migration appears only in the gradient region and 
neighter the compliant nor the rigid substrate trigerred this effect. It was further 
demonstrated  that directed movement occurs only in the axis corresponding to the gradient. 
 
This initial research, involving experiments mimicking physiological conditions in which 
Tumour Stromal Myofibroblasts in a fibrotic tissue are exposed to various microenvironment 
stiffness, revealed that cells are able to migrate from healthy to fibrotic stiffness substrate 
and can contribute to the progression of the disease. 
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stiffness 
[kPa] 
acrylamide 
concentration 
% 
PBS 
volume 
[µl] 
APS 
[µl] 
TEMED 
[µl] 
acrylamide/bisacrylamide 
(29:1) 40% vol [µl] 
1.3 2.7 461.6 2.5 1 34.9 
4 4.6 437.1 2.5 1 59.4 
12 6.1 417.7 2.5 1 78.8 
14.8 7.6 398.3 2.5 1 98.2 
25 9.7 371.2 2.5 1 125.3 
Table 1 Reagents proportion to obtain polyacrylamide gel with desired rigidity 
Figure 1 Schematic of double rigidity polyacrylamide gel to study cell 
durotactic response 
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